9th Annual Biomarkers Congress 2014

Oxford Global Con­fer­ences Ltd are proud to present the 9^th Annual Bio­mark­ers Con­gress 2014, tak­ing place on 25 & 26 Feb­ru­ary 2014 in Man­ches­ter, United King­dom.

The increas­ing inter­est in bio­marker dis­cov­ery in recent years has pushed bio­marker research into the fore­ground of the mod­ern phar­ma­ceu­ti­cal indus­try. New iden­ti­fi­ca­tion tech­nolo­gies have both widened the scope of bio­marker research and under­lined the need for robust val­i­da­tion, improved pre­dic­tive value and the clear demon­stra­tion of clin­i­cal relevance.

The Bio­mark­ers Con­gress will cover the lat­est advances in bio­marker dis­cov­ery and ver­i­fi­ca­tion, includ­ing mass cytom­e­try, selected reac­tion mon­i­tor­ing and chem­i­cal genetics.

Our expert speak­ers will also dis­cuss efforts to increase bio­marker sen­si­tiv­ity and speci­ficity through genomic analy­sis, infor­mat­ics approaches and bet­ter sam­ple man­age­ment. In the Com­pan­ion Diag­nos­tics stream, pre­sen­ta­tions will cover emerg­ing tech­nolo­gies, opti­mi­sa­tion of exist­ing plat­forms and strate­gies to improve strate­gic partnerships.

To build on the clin­i­cal case stud­ies shared at last year’s event, we are pleased to intro­duce the co-​located “Bio­mark­ers in Clin­i­cal Devel­op­ment Con­gress”, focus­ing on the role of bio­mark­ers in clin­i­cal deci­sion mak­ing, drug effi­cacy pre­dic­tion and clin­i­cal safety. Key deci­sion mak­ers in per­son­alised med­i­cine will com­ple­ment these dis­cus­sions with their insights into phar­ma­coge­nomics, strat­i­fi­ca­tion mark­ers and pre­ci­sion medicine.

Bio­mark­ers In Dis­cov­ery & Pre­clin­i­cal Development

(Day 1 Stream 1)

• Safety bio­mark­ers: val­i­da­tion and regulation
• Bio­marker research: key learn­ings from pre­clin­i­cal mod­els and exper­i­men­tal medicine
• PK/​PD stud­ies: pre­dic­tive sci­ence from a bio­marker perspective
• Imag­ing bio­mark­ers: new technologies
• Bio­marker out­sourc­ing strategies
• Cap­tur­ing real-​world data in bio­marker research

Com­pan­ion Diagnostics

(Day 1 Stream 2)

• How best to mature emerg­ing tech­nolo­gies into com­pan­ion diagnostics
• Com­pan­ion diag­nos­tics in can­cer drug development
• Human tis­sue col­lec­tion in diag­nos­tics research
• Strate­gic part­ner­ship best prac­tice in com­pan­ion diag­nos­tics development
• Opti­mis­ing tar­gets and plat­forms for the devel­op­ment of bio­med­ical diagnostics

Bio­marker Dis­cov­ery & Verification

(Day 2 Stream 1)

• Bio­marker analy­sis: tech­nolo­gies & platforms
• Devel­op­ment and val­i­da­tion of chal­leng­ing bio­marker assays
• Appli­ca­tions of selected reac­tion mon­i­tor­ing in pharma
• Infor­mat­ics in bio­marker discovery
• Mass cytom­e­try: a promis­ing novel tech­nol­ogy for bio­marker discovery
• Big data inno­va­tion in bio­marker research
• The role of biobank­ing in bio­marker research

Inno­va­tions In Bio­marker Research

(Day 2 Stream 2)

• Col­lab­o­ra­tive strate­gies: build­ing on the suc­cess of safety bio­marker initiatives
• Lat­est updates from cor­rel­a­tive sci­ence teams
• New advances in cir­cu­la­tion tumour cell research
• Novel bio­marker iden­ti­fi­ca­tion meth­ods: exploit­ing struc­ture and chem­i­cal genetics
• Inno­va­tion case stud­ies: oncol­ogy and res­pi­ra­tory biomarkers

Clin­i­cal Biomarkers

(Day 1)

• Bio­marker devel­op­ment and clin­i­cal application
• Bio­marker research: a clinician’s perspective
• Trans­lat­ing bio­mark­ers into clin­i­cal assays
• Clin­i­cal genet­ics: devel­op­ing diag­nos­tic assays with clin­i­cal utility
• Fit for pur­pose devel­op­ment of clin­i­cal biomarkers
• Suc­cess­ful clin­i­cal val­i­da­tion of biomarkers

Clin­i­cal Tri­als & Per­son­alised Medicine

(Day 2)

• Advanc­ing per­son­alised med­i­cine: case stud­ies from clin­i­cal teams
• Per­son­alised med­i­cine and phar­ma­coge­nomics: the generic company’s perspective
• Find­ing the right patient pop­u­la­tion: min­ing clin­i­cal study data
• Pre­ci­sion med­i­cine: updates from large pharma
• Devel­op­ing patient selec­tion markers
• Iden­ti­fy­ing the right patient for tar­geted therapy

Who will attend

The 9^th Annual Bio­mark­ers Con­gress is an exclu­sive event designed for senior level atten­dees from lead­ing phar­ma­ceu­ti­cal, bio­phar­ma­ceu­ti­cal, biotech­nol­ogy, diag­nos­tics, CRO and solu­tion provider com­pa­nies, along with highly esteemed mem­bers of aca­d­e­mic and gov­ern­ment institutions.

Del­e­gates typ­i­cally include VPs, Direc­tors and Global Heads of:

• Adap­tive trial design
• Assay devel­op­ment
• Assay val­i­da­tion
• Biobank­ing
• Bioin­for­mat­ics
• Bio­marker development
• Bio­marker identification
• Bio­marker validation
• Bio­marker discovery
• Clin­i­cal safety
• Com­pan­ion diagnostics
• Immunoas­says
• Patient strat­i­fi­ca­tion
• Per­son­alised medicine
• Phar­ma­coge­nomics
• PK/​PD
• Pre­ci­sion medicine
• Rx/​Dx co-​development

Sub­mit a Poster

For atten­dees inter­ested in sub­mit­ting a poster, there are oppor­tu­ni­ties now avail­able. Your poster pre­sen­ta­tion will be located in the exhi­bi­tion room for two days along­side other posters from senior sci­en­tists work­ing in indus­try and academia.

We will require:

• Poster title, Abstract (200 words or less)
• Prin­ci­pal author, Organ­i­sa­tion, Mail­ing address, Email, Tele­phone, Fax
• Addi­tional authors

In order to secure your board space a fee of £125 will be required.

To take advan­tage of this oppor­tu­nity you need to be reg­is­tered as a paid del­e­gate over the 2 days. We have lim­ited spaces avail­able, so please reg­is­ter soon!

Advi­sory Board

Our 2014 Advi­sory Board includes

• Corinne Solier – Group Head, Clin­i­cal Pro­tein Bio­mark­ers, Roche
• Terry Robins – Direc­tor, Bio­marker Research and Devel­op­ment & Global Sci­en­tific Affairs, Quest Diagnostics
• John Allinson – VP Bio­marker Lab Ser­vices, Icon
• Khusru Asadul­lah – VP and Head of Global Bio­marker, Bayer Health Care
• Stephen Roy Pen­ning­ton – Pro­fes­sor of Pro­teomics, Uni­ver­sity Col­lege Dublin
• Alain Van Gool, Pro­fes­sor – Senior Sci­en­tist Inte­gra­tor Meta­bolic Health Research, TNO